ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.65
0.00%
US Tech 100
20,945.20
0.54%
S&P 500
6,039.31
-0.47%
US Dollar vs CAD
1.44137
0.09%
Bitcoin
105,168.69
1.38%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Brazil
  5. BOV

  6. Abbott Laboratories (ABTT34) Share Price

Abbott Laboratories

Abbott Laboratories (ABTT34)

BOV
62.09
0.00
(0.00%)
Closed January 30 2:55PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
62.09
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
43.47 52 Week Range 63.82
Market Cap
107.792B
Previous Close
62.09
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
667
Shares Outstanding
1,736,059,000
Dividend Yield
1.34%
PE Ratio
38.79
Earnings Per Share (EPS)
3.3
Revenue
40.11B
Net Profit
5.72B

About Abbott Laboratories

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.abbott.com
Headquarters
Chicago, Illinois, USA
Founded
-
Abbott Laboratories is listed in the Pharmaceutical Preparations sector of the Brazil Bovespa Exchange with ticker ABTT34. The last closing price for Abbott Laboratories was R$62.09. Over the last year, Abbott Laboratories shares have traded in a share price range of R$ 43.47 to R$ 63.82.

Abbott Laboratories currently has 1,736,059,000 shares outstanding. The market capitalization of Abbott Laboratories is R$107.79 billion. Abbott Laboratories has a price to earnings ratio (PE ratio) of 38.79.

Ask ADVFN Intelligence (AI)

ABTT34 Latest News

More News
No news to show yet.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
14.257.3478561549157.8463.8257.8414761.15617687DR
44.197.236614853257.963.8253.5836557.66813404DR
127.4313.593121112354.6663.8253.5866757.88069234DR
2612.625.45968882649.4963.8249.242256.49359996DR
5217.0837.947122861645.0163.8243.4738852.61224057DR
1566.5422267211.777657921655.5477732863.8237.5167446.49576074DR
26030.5026392796.565963616731.5873607367.4063615528.75849266111348.35304582DR

ABTT34 - Frequently Asked Questions (FAQ)

What is the current Abbott Laboratories share price?
The current share price of Abbott Laboratories is R$ 62.09
How many Abbott Laboratories shares are in issue?
Abbott Laboratories has 1,736,059,000 shares in issue
What is the market cap of Abbott Laboratories?
The market capitalisation of Abbott Laboratories is BRL 107.79B
What is the 1 year trading range for Abbott Laboratories share price?
Abbott Laboratories has traded in the range of R$ 43.47 to R$ 63.82 during the past year
What is the PE ratio of Abbott Laboratories?
The price to earnings ratio of Abbott Laboratories is 38.79
What is the cash to sales ratio of Abbott Laboratories?
The cash to sales ratio of Abbott Laboratories is 5.53
What is the reporting currency for Abbott Laboratories?
Abbott Laboratories reports financial results in USD
What is the latest annual turnover for Abbott Laboratories?
The latest annual turnover of Abbott Laboratories is USD 40.11B
What is the latest annual profit for Abbott Laboratories?
The latest annual profit of Abbott Laboratories is USD 5.72B
What is the registered address of Abbott Laboratories?
The registered address for Abbott Laboratories is 208 SO LASALLE ST, SUITE 814, CHICAGO, ILLINOIS, 60604-1101
What is the Abbott Laboratories website address?
The website address for Abbott Laboratories is www.abbott.com
Which industry sector does Abbott Laboratories operate in?
Abbott Laboratories operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ABCB4Banco ABC Brasil S.A.
R$ 19.81
(0.00%)
0
AALR3RAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3QAllianca Saude e Participacoes S.A.
R$ 14.95
(0.00%)
0
AALR3MAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3Allianca Saude e Participacoes S.A.
R$ 11.35
(0.00%)
0
ABCB4Banco ABC Brasil S.A.
R$ 19.81
(0.00%)
0
AALR3RAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3QAllianca Saude e Participacoes S.A.
R$ 14.95
(0.00%)
0
AALR3MAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3Allianca Saude e Participacoes S.A.
R$ 11.35
(0.00%)
0
ABCB4Banco ABC Brasil S.A.
R$ 19.81
(0.00%)
0
AALR3RAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3QAllianca Saude e Participacoes S.A.
R$ 14.95
(0.00%)
0
AALR3MAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3Allianca Saude e Participacoes S.A.
R$ 11.35
(0.00%)
0

Discussion

View Full Feed
bigstocksnbonds bigstocksnbonds 3 minutes ago
Sounds like a good back up plan!!
SHORENUFFSTUFF SHORENUFFSTUFF 3 minutes ago
Bet you didn't know this................
Koi fish travel in groups of 4 for safety. Kois A, B,and C flee the trouble, leaving behind the D koi.

I once lost my watch at a party.
An hour later, I saw some guy stepping on it while he was harassing some woman.
Inf
John_Vallay John_Vallay 5 minutes ago
How can BSEG make films, with or without using AI, when they only have $40,936 in cash.
Please do not tell me about their $565,031 in accounts receivables because that has been there for many years and it has not been collected. I am somewhat surprised BSEG auditors don't make them write it o
BSEG
lakers17 lakers17 5 minutes ago
More dilution. AFFU has been so damn disappointing.
AFFU
theorysuit theorysuit 6 minutes ago
over 20 since this trial started, 7 years since this trial ended, and 4.5 years since data lock...

and you are talking about foot in the door in a trivial market at this point in their history? What about making a profit....nowhere in sight. That is pathetic. Why? Because the
NWBO
eur06 eur06 7 minutes ago
If those contracts are for real it’s time to add imo.
UMAV
UMAV
abracky abracky 7 minutes ago
style="font-size: 16px"Here is What to Know Beyond Why Cleveland-Cliffs Inc. (CLF) is a Trending Stock https://finance.yahoo.com/news/know-beyond-why-cleveland-cliffs-140010688.html
CLF
ttottip ttottip 8 minutes ago
Technological revolution in China!
HOLO
Bull_Dolphin Bull_Dolphin 9 minutes ago
Ex president of Kenya gets it:

https://x.com/libsoftiktok/status/1884641033658433783
RIGATONI RIGATONI 11 minutes ago
Good morning! ~Rig
jimmybob jimmybob 11 minutes ago
UPB in da HIZZLE
jimmybob jimmybob 11 minutes ago
GM FOLKSS
uranium-pinto-beans uranium-pinto-beans 12 minutes ago
$TSLA

🔸 Jefferies maintained a Hold rating on Tesla with a price target of $300

🔸 Baird reduced the price target for Tesla to $440 from $480 but kept the Outperform rating

🔸 Piper Sandler reaffirmed an Overweight rating with a pric
TSLA
ttottip ttottip 12 minutes ago
https://www.reuters.com/technology/artificial-intelligence/alibaba-releases-ai-model-it-claims-surpasses-deepseek-v3-2025-01-29/
HOLO
docterox docterox 13 minutes ago
yeah , big bag over 13mil 0015
DBMM
danieldeubank danieldeubank 13 minutes ago
Jim Sims making the case for domestic REEs

https://www.linkedin.com/posts/cesarconda_pentagon-nationalsecurity-foreignpolicy-activity-7290508326080040960-U9h3?utm_medium=ios_app&utm_source=social_share_sheet&utm_campaign=copy_link
NB
zab zab 14 minutes ago
Fox News is always so nice with a republican administration,  an accident at Washington DC airport,  it will takes months to understand. Fortunately not many were killed. 
uranium-pinto-beans uranium-pinto-beans 15 minutes ago
AAPL, GOOG, GOOGL
Federal judge denies Apple effort to intervene in Google search remedy trial
A U.S. federal judge denied a motion by Apple (AAPL) to intervene as a defendant in the remedy trial of the DOJ vs. Google (GOOGL) case, saying Apple's motion was untimely. Apple made the
AAPL GOOG
uranium-pinto-beans uranium-pinto-beans 16 minutes ago
Meta Platforms price target raised to $750 from $680 at Baird
Baird analyst Colin Sebastian raised the firm's price target on Meta Platforms to $750 from $680 and keeps an Outperform rating on the shares post the Q4 report. The firm says "very upbeat commentary" from Mark Zuckerberg on Meta's
uranium-pinto-beans uranium-pinto-beans 16 minutes ago
Meta Platforms price target raised to $800 from $650 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised the firm's price target on Meta Platforms to $800 from $650 and keeps an Outperform rating on the shares, but acknowledges risk to out-year revenue estimates. Investors must now beli
uranium-pinto-beans uranium-pinto-beans 16 minutes ago
Meta Platforms price target raised to $770 from $700 at Wedbush
Wedbush raised the firm's price target on Meta Platforms to $770 from $700 and keeps an Outperform rating on the shares. The firm notes Meta reported strong Q4 results with revenue 3% ahead of the Street and operating income abou
uranium-pinto-beans uranium-pinto-beans 16 minutes ago
UPS
UPS reports Q4 adjusted EPS $2.75, consensus $2.53
Reports Q4 revenue $25.3B, consensus $25.42B. "I want to thank all UPSers for their hard work and efforts as we closed out 2024 with an outstanding peak, delivering best-in-class service and strong financial results ahead of our
Investor082 Investor082 16 minutes ago
Why gaslight then if you don't believe in it?
NWBO
zab zab 17 minutes ago
Fox News reports,  it's unfortunate,  accidents happen,  that's why pilots train.

Your Recent History

BOV
ABTT34
Abbott Laboratories
BIT
NSCIT5365316
Imi Fabi
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads